Lilly sells Actos sales rights to Takeda-WEB ONLY
Eli Lilly and Co. has sold the rights to sell the diabetes drug Actos in seven countries to Takeda Pharmaceutical Co., Asia’s biggest drugmaker, Bloomberg News reported this morning. Takeda will sell Actos in Canada, Belgium, Denmark, Norway, Sweden and Turkey, a company spokesman told Bloomberg yesterday. Terms of the deal were not disclosed. Takeda […]